share_log

EXCLUSIVE: ProSomnus Tells Benzinga Co. Sees Preliminary FY22 Revenue Up 35% YoY; Says Surpassed 187,500 Devices Prescribed By Healthcare Providers

EXCLUSIVE: ProSomnus Tells Benzinga Co. Sees Preliminary FY22 Revenue Up 35% YoY; Says Surpassed 187,500 Devices Prescribed By Healthcare Providers

獨家:普羅姆努斯告訴賓辛加有限公司.22 財政年度初步收入同比增長 35%;據醫療保健提供者規定超過 187,500 台設備
Benzinga Real-time News ·  2023/02/01 16:39

EXCLUSIVE: ProSomnus Tells Benzinga Co. Sees Preliminary FY22 Revenue Up 35% YoY; Says Surpassed 187,500 Devices Prescribed By Healthcare Providers

獨家報道:ProSomnus告訴Benzinga Co.預計2012財年初步收入同比增長35%;表示超過醫療保健提供商開出的187,500臺設備

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論